← Calendar
Ticker

IRD

Opus Genetics, Inc.

15 catalysts on file

IRD
Opus Genetics, Inc.
Phase 3 AI-extracted
OPGx-LCA5
Leber Congenital Amaurosis (LCA) due to biallelic mutations in the LCA5 gene
T-minus 178 days ~ Dec 31, 2026
SEC 8-K verified 12h ago
Countdown card β†’